Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000003863 | SCV004291759 | uncertain significance | UDPglucose-4-epimerase deficiency | 2023-04-20 | criteria provided, single submitter | clinical testing | Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt GALE protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on GALE function (PMID: 9973283, 11117433, 16302980). ClinVar contains an entry for this variant (Variation ID: 3678). This missense change has been observed in individual(s) with galactose epimerase deficiency (PMID: 9538513). This variant is present in population databases (rs28940883, gnomAD 0.003%). This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 103 of the GALE protein (p.Asp103Gly). |
OMIM | RCV000003863 | SCV000024028 | pathogenic | UDPglucose-4-epimerase deficiency | 1998-01-01 | no assertion criteria provided | literature only |